Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ann Surg. 2022 Jul 22;278(2):267–273. doi: 10.1097/SLA.0000000000005625

Table 5:

Results and Follow-up of Operative and Non-operative management.

Operative
Management
Number (%)
Non-Operative
Management
Number (%)
P value
Median Follow-Up 3.0 years (IQR 1.0 – 5.5) 1.9 years (IQR 0.8 – 4.2)
Status at Last Contact N=212 N=116
Recurrence 4 (1.9) 0
Disease Free Post Excision 179 (84.4) 4* (3.4)
Residual disease 18 (8.5) 0
Ganglioneuroma still present 0 103 (88.8)
Unknown status 11 (5.2) 9 (7.8)
Living Status N=212 N=116 0.46
Alive 199 (93.9) 112 (96.5)
Dead 6 (2.8) 1 (0.9)
Unknown status 7 (3.3) 3 (2.6)
Functional Deficits N=212 N=116 0.75
Neurological sequelae 6 (2.8) 2 (1.7)
Bladder dysfunction 2 (0.9) 0
Bowel dysfunction 4 (1.9) 1 (0.9)
Bladder and Bowel Dysfunction 1 (0.5) 0
Lower limb edema 1 (0.5) 2 (1.7)
Persistent pain 8 (3.8) 5 (4.3)

Frequencies are reported in parentheses. Chi Square test or Fisher’s exact test were used to calculate significance.

*

Disease-free Post Biopsy.